| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/08/2008 | US7316914 Comprises cassettes derived from regulatory region of methylenomycin gene cluster of Streptomyces plasmid |
| 01/08/2008 | US7316912 Tyrosylprotein sulfotransferases and methods of use thereof |
| 01/08/2008 | CA2331781C De novo dna cytosine methyltransferase genes, polypeptides and uses thereof |
| 01/08/2008 | CA2245173C Manufacture of xylanase complex using pre-treated thin stillage of rye |
| 01/08/2008 | CA2225183C Novel foam proteins and use thereof |
| 01/08/2008 | CA2203631C Cyclic peptide obtained from actinomyces s. nobilis useful as therapeutic agent |
| 01/08/2008 | CA2181164C Anti-gram-positive bacterial methods and materials |
| 01/08/2008 | CA2163868C Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them |
| 01/08/2008 | CA2128794C Mutant aox2 promoter, vector carrying same, transformant, and production of heterologous protein |
| 01/08/2008 | CA2104111C Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 01/04/2008 | CA2595164A1 An antibody which recognizes phosphorylated polypeptides |
| 01/04/2008 | CA2591804A1 Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases |
| 01/04/2008 | CA2557772A1 Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases |
| 01/04/2008 | CA2551537A1 Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases |
| 01/03/2008 | WO2008002661A2 Fusion protein constructs |
| 01/03/2008 | WO2008001947A1 MUTANT SepRS, AND METHOD FOR SITE-SPECIFIC INTRODUCTION OF PHOSPHOSERINE INTO PROTEIN BY USING THE SAME |
| 01/03/2008 | WO2008001837A1 Method for purification of oligopeptide |
| 01/03/2008 | WO2008001597A1 Method for production of protein |
| 01/03/2008 | WO2008000079A1 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
| 01/03/2008 | WO2007131182A3 System for high production of natural and personalized interferons |
| 01/03/2008 | WO2007075845A3 Isolated mcpip and methods of use |
| 01/03/2008 | WO2005079232A3 A METHOD FOR THE PRODUCTION OF AN ERYTHROPOIETIN ANALOG-HUMAN IgG FUSION PROTEINS IN TRANSGENIC MAMMAL MILK |
| 01/03/2008 | WO2005010166A3 P450 oxygenases and methods of use |
| 01/03/2008 | WO2004081226A3 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use |
| 01/03/2008 | US20080004231 Disease-Associated Protein |
| 01/03/2008 | US20080004186 Systematic evaluation of sequence and activity relationships using site evaluation libraries for engineering multiple properties |
| 01/03/2008 | US20080003679 Cell culture medium |
| 01/03/2008 | US20080003647 in vitro biosynthesis; Lactobacillus, Streptococcus, Enterococcus strains |
| 01/03/2008 | US20080003646 Stable, humanized, high affinity antibodies against carcinoembryonic antigen (CEA); complementary determining regions; vectors, host cells; pharmacokinetics |
| 01/03/2008 | US20080003645 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 01/03/2008 | US20080003644 Process for Obtaining Antibodies |
| 01/03/2008 | US20080003643 Methods of Synthesizing Heteromultimeric Polypeptides in Yeast Using a Haploid Mating Strategy |
| 01/03/2008 | US20080003642 Creation of diversity in polypeptides |
| 01/03/2008 | US20080003641 The production of high-activity superoxide dismutase (sod) and application in methods of both the solid-state and liquid-state fermentation |
| 01/03/2008 | US20080003639 Comprising a polynucleotide encoding a polypeptide, wherein the polypeptide hydroxylates the 24-position of an oleanane-type triterpene; cell transformed by a genetic engineering technique with an enzyme gene which is concerned in biosynthesis of plant-derived soyasapogenol B (12-oleanene-3,22,24-triol) |
| 01/03/2008 | US20080003611 Heat lysis production of proteins |
| 01/03/2008 | US20080003580 sequentially providing two or more charged tRNA during in vitro protein synthesis; directed protein evolution |
| 01/03/2008 | US20080003570 Translation enhancer elements of genes encoding human Tau protein and human alpha-synuclein protein |
| 01/03/2008 | US20080003243 Oral Anti-Protozoiasis Vaccines Based on Transgenic Plants |
| 01/03/2008 | US20080003237 Gram Positive Bacterial Cells Comprising a Disrupted Flagellin Gene, Flagellin-Based Fusion Proteins and Use in Removal of Metal Ions from a Liquid |
| 01/03/2008 | US20080003236 Adenovirus fiber shaft composition and methods of use |
| 01/03/2008 | US20080003227 Acetyl CoA Carboxylase Splice Variant and Uses Thereof |
| 01/03/2008 | US20080003224 Compositions and methods for treating haematological proliferative disorders |
| 01/03/2008 | US20080003218 Anti-IgE antibodies |
| 01/03/2008 | US20080003212 ATP Diphosphohydrolase (CD39) Gene Therapy for Inflammatory or Thrombotic Conditions for Transplantation and Means Therefor |
| 01/03/2008 | US20080003210 Non-human primate receptor tyrosine kinases |
| 01/03/2008 | US20080003202 Modified interferon-beta (IFN-beta) polypeptides |
| 01/03/2008 | DE3890998B4 Neutrophilenaktivierungsfaktor, Verfahren zu seiner Herstellung und ihn enthaltende pharmazeutische Zusammensetzung Neutrophilenaktivierungsfaktor, process for its preparation and pharmaceutical composition containing it |
| 01/03/2008 | CA2656322A1 Methods for arbitrary peptide synthesis |
| 01/03/2008 | CA2653756A1 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
| 01/02/2008 | EP1873259A1 RNA interference is mediated by 21 and 22nt small RNAs |
| 01/02/2008 | EP1873245A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/02/2008 | EP1873164A1 High molecular weight poly-gamma-glutamic acid (> 2000 kDa) |
| 01/02/2008 | EP1871804A2 Reagents that bind ccx-ckr2 |
| 01/02/2008 | EP1871418A2 Humanized anti-cd70 binding agents and uses thereof |
| 01/02/2008 | EP1660646A4 Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use |
| 01/02/2008 | EP1432802B1 Pegylated and diglycosylated erythropoietin |
| 01/02/2008 | EP1425397B1 Modified cry3a toxins and nucleic acid sequences coding therefor |
| 01/02/2008 | EP1028978B1 Methods of preparing glycosylated antibodies and antibody fragments having reactive ketone groups |
| 01/02/2008 | EP0942934B1 Receptor tyrosine kinase genes |
| 01/02/2008 | EP0920514B1 Targeting adenovirus with use of constrained peptide motifs |
| 01/02/2008 | EP0830139B1 Modified myelin protein molecules |
| 01/02/2008 | EP0722499B1 Immunoreactive antigens of hepatitis e virus |
| 01/02/2008 | EP0610335B1 Methods for designing recombitope peptides |
| 01/02/2008 | CN101098886A Production of proteins |
| 01/02/2008 | CN101098882A Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 01/02/2008 | CN101096698A Preparation technology for soybean oligopeptide with high F-value |
| 01/02/2008 | CN101096697A Industrial production method of ovum protein polypeptide from fowl ovum by enzymatical process |
| 01/02/2008 | CN101096696A Industrial production method of corn protein polypeptide from corn protein powder by enzymatical process |
| 01/02/2008 | CN101096382A Aglyco products and methods of use |
| 01/02/2008 | CN100359327C Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 01/02/2008 | CN100359018C Bioengineering egg products and preparation method thereof |
| 01/02/2008 | CN100359015C Human tumour-derived polyptde hormone phosphatonin |
| 01/02/2008 | CN100359013C Modified promoter |
| 01/02/2008 | CN100359001C Compartmentalization of recombinant polypeptides in host cells |
| 01/01/2008 | US7314925 Vectors comprise avian lysozyme leader peptide for targetting the endoplasmic reticulum; heparin affinity chromatography |
| 01/01/2008 | US7314920 Antibodies against the PRO4340 polypeptide |
| 01/01/2008 | US7314918 PRO6246 antibodies |
| 01/01/2008 | US7314915 Fluorescent proteins |
| 01/01/2008 | US7314914 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 01/01/2008 | US7314913 PRO1891 polypeptides |
| 01/01/2008 | US7314910 In situ diagnosis, detection of antibodies, immunogenic formulations |
| 01/01/2008 | US7314869 Vaccine vector comprising isolated nucleic acid molecule which encodes sequence 2 linked to promoter |
| 01/01/2008 | US7314864 Isolated polypeptid of 24-amino acids; the clone suppressed neuronal death induced by all of the known types of early-onset familial Altzheimers Disease genes |
| 01/01/2008 | US7314845 Supported catalyst systems |
| 01/01/2008 | US7314754 Polynucleotide encoding the hOT7T175 G protein coupled receptor |
| 01/01/2008 | US7314743 Xylanases having increased stability in harsh industrial environments, such as increased pH and/or temperature |
| 01/01/2008 | US7314742 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
| 01/01/2008 | US7314737 Method of effecting a change in a cell, and a vector |
| 01/01/2008 | US7314736 Nucleic acids encoding oxidation-reduction sensitive green fluorescent protein variants |
| 01/01/2008 | US7314735 Deposited in flat, structural platelets in reflective tissues of the squid Euprymna scolopes; protein-based reflectors in squids provide a striking example of nanofabrication in animal systems |
| 01/01/2008 | US7314734 Muteins of placental growth factor type 1, preparation method and application thereof |
| 01/01/2008 | US7314733 Nucleotide sequences coding tau protein for use as diagnostic tool in detection of alzheimer's and neurodegenerative disorders |
| 01/01/2008 | US7314730 Identifying modulator which inhibit membrane bound protease activity for use in treatment and prevention of atherosclerosis, infections, inflammation, cell proliferative, neurodegenerative and respiratory system disorders |
| 01/01/2008 | US7314719 to soil microorganism (Streptomyces, Bacillus, and Pseudomonas) that produce agriculturally and/or medically useful antibiotics and biologically active substances |
| 01/01/2008 | US7314710 Method for replicating the hepatitis C virus |
| 01/01/2008 | US7314627 Cationic lipid-mediated enhancement of nucleic acid immunization of cats |
| 01/01/2008 | US7314626 Peptide antibiotic conjugate for use in recognition and elimination of infections agents or neoplasms; antitumor agents; bactericides |
| 01/01/2008 | US7314625 Generating polyclonal antisera that reduce adherence of the microorganism expressing the Type IV pilin loop sequence to the epithelial cells |
| 01/01/2008 | US7314621 Gene ecodeing protein; activation; cloning; DNA libraries from rodents |